Hip Disability Score
Hip Disability Score - Related Videos
08:11
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
0 Views •
Cited by 21 •
2016
An optimized testing protocol is presented in this paper for the Rotarod performance test, used for measuring progressive neurological disability in TMEV-infected mice.
01:29
Intellectual Disability
0 Views •
2025
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
01:25
Learning Disabilities
0 Views •
2025
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning. Dyslexia Dyslexia is a...
09:38
Quantitative Assessment of Cortical Auditory-tactile Processing in Children with Disabilities
0 Views •
Cited by 8 •
2014
Objective and easy measurement of sensory processing is extremely difficult in nonverbal or vulnerable pediatric patients. We developed a new methodology to quantitatively assess infants and children's cortical processing of light touch, speech sounds, and the multisensory processing of the 2 stimuli, without requiring active subject participation or causing discomfort in vulnerable patients.
11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
0 Views •
Cited by 106 •
2014
Precise measurement of neurological and neuropsychological impairment and disability in multiple sclerosis is challenging. We report methodologic details on a new test, the Multiple Sclerosis Performance Test (MSPT). This new approach to the objective of quantification of MS related disability provides a computer-based platform for precise, valid measurement of MS severity.
FAQs
The score brings together several clinically relevant dimensions rather than focusing on pain alone. Its assessment covers pain, mobility, daily activities, and overall function, allowing clinicians to view how hip disease affects both symptoms and practical performance. This broader profile helps distinguish symptom burden from limitations in routine movement and activity.
Patient-reported responses document the individual’s experience of pain and functional limitation, while standardized scoring converts those responses into a consistent numerical measure. Combining both elements supports reproducible assessment across visits and patients. The approach also connects a measurable clinical outcome with limitations that may not be fully represented by examination findings alone.
A change between assessments can indicate that hip-related disability has improved or deteriorated, but its meaning depends on when the measurements were collected and what intervention or recovery period occurred between them. Comparing scores with the baseline helps clinicians follow the patient’s trajectory rather than interpreting a single value in isolation.
The workflow begins by collecting the patient’s responses about hip pain, mobility, daily activities, and function. Those responses are then processed through standardized scoring to produce a numerical result. Clinicians can record the baseline value, repeat the assessment during follow-up, and compare results to evaluate recovery or changing disability.
Clinicians may use it when characterizing disability associated with hip osteoarthritis, hip injury, or postoperative rehabilitation. Establishing a baseline can describe the patient’s initial functional burden, while repeated assessments can help monitor recovery after treatment. Its coverage of daily activities makes it relevant when symptoms need to be related to practical function.
In research, the score provides a reproducible outcome for describing hip-related disability and evaluating change over time. Investigators can use it to compare outcomes between therapeutic approaches while retaining information about patients’ lived functional limitations. This makes the measure useful for linking treatment-related findings with pain, mobility, daily activities, and overall function.